Vega BioImaging develops plasmonic nanoparticles for use as optical markers in biochemical and biomedical diagnostics, enabling quantitative, multi-target protein detection in biopsies. Their technology enhances diagnostic accuracy by providing five times more precise protein quantification and the ability to detect up to four markers simultaneously, all while maintaining compatibility with standard H&E staining.
Funding
$134.8K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CFounders
Product
Problem
Current methods for protein detection in biopsies lack precise quantification and are limited in the number of targets that can be simultaneously analyzed, hindering diagnostic accuracy. Traditional techniques often require specialized equipment and extensive training, creating barriers to rapid and comprehensive analysis.
Solution
Vega BioImaging offers plasmonic nanoparticles designed as optical markers for biochemical and biomedical diagnostics, enabling quantitative and multi-target protein detection in biopsies. Their technology enhances diagnostic precision by providing five times more accurate protein quantification and the ability to detect up to four markers concurrently. The approach is compatible with standard Hematoxylin and Eosin (H&E) staining, allowing for seamless integration into existing workflows. The system includes diagnostic kits with colored beads targeting specific proteins, AI-powered software for marker quantification, and a slide scanner adapted for the specific marking.
Target Audience
The primary users are cytopathologists and histopathologists requiring quantitative and multiplexed protein analysis for more precise cancer diagnostics.
Features
- Plasmonic nanoparticles for use as optical markers in biopsies
- Quantitative protein detection with five times more precision than current techniques
- Multi-target detection of up to four proteins simultaneously
- Compatibility with standard H&E staining for seamless integration
- Diagnostic kits with colored beads designed to target the desired protein
- AI-powered software for quantification of the marking agent
- Slide scanner adapted for specific marking
- Immunoplasmonic marking eliminates photo-bleaching, enabling multiple examinations of the same sample